Literature DB >> 19135154

The personality trait openness is related to cerebral 5-HTT levels.

Jan Kalbitzer1, Vibe G Frokjaer, David Erritzoe, Claus Svarer, Paul Cumming, Finn A Nielsen, Sayed H Hashemi, William F C Baaré, Jacob Madsen, Steen G Hasselbalch, Morten L Kringelbach, Erik L Mortensen, Gitte M Knudsen.   

Abstract

Potentiation of serotonergic transmission increases cognitive flexibility, but can in other circumstances increase sensitivity to stressful environmental cues. The personality trait Openness to Experience reflects and is also associated with an increased risk for mood disorders. We hypothesized that the personality trait has an association with a biomarker of serotonergic transmission, the plasma membrane serotonin transporter (5-HTT). In 50 healthy volunteers, we tested for correlations between scores on the NEO-PI-R scale Openness to Experience and its subscales, and cerebral binding of the 5-HTT selective PET radioligand [11C]DASB. Subjects were genotyped for the 5-HTT long/short polymorphism, and for a single nucleotide polymorphism in the long allele, designated LA/LG. Midbrain [11C]DASB binding correlated negatively with scores for Openness to Experience and its two subscales, Openness to Actions and Openness to Values. The latter subscore was negatively correlated with [11C]DASB binding in all brain regions in which [11C]DASB binding was quantified. Genetic analysis showed that homozygote LA carriers had significantly higher [11C]DASB binding in the caudate nucleus, but no significant differences in openness scores. Thus, high scores in personality facets indicative of cognitive flexibility and openness to change are associated with lower [11C]DASB binding. Lower abundance of 5-HTT sites may result in potentiation of serotonergic signaling, which occurs during treatment with SSRIs. We speculate that the set-point of serotonergic signaling in an individual represents a trade-off between flexibility and vulnerability when exposed to environmental stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19135154     DOI: 10.1016/j.neuroimage.2008.12.001

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  30 in total

Review 1.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

Review 2.  How the cerebral serotonin homeostasis predicts environmental changes: a model to explain seasonal changes of brain 5-HTT as intermediate phenotype of the 5-HTTLPR.

Authors:  Jan Kalbitzer; Urs Kalbitzer; Gitte Moos Knudsen; Paul Cumming; Andreas Heinz
Journal:  Psychopharmacology (Berl)       Date:  2013-10-23       Impact factor: 4.530

3.  Age and sex effects on 5-HT(4) receptors in the human brain: a [(11)C]SB207145 PET study.

Authors:  Karine Madsen; Mette T Haahr; Lisbeth Marner; Sune H Keller; William F Baaré; Claus Svarer; Steen G Hasselbalch; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-02       Impact factor: 6.200

4.  5-HTTLPR differentially predicts brain network responses to emotional faces.

Authors:  Patrick M Fisher; Cheryl L Grady; Martin K Madsen; Stephen C Strother; Gitte M Knudsen
Journal:  Hum Brain Mapp       Date:  2015-04-30       Impact factor: 5.038

5.  Cognitive function is related to fronto-striatal serotonin transporter levels--a brain PET study in young healthy subjects.

Authors:  Karine Madsen; David Erritzoe; Erik Lykke Mortensen; Anders Gade; Jacob Madsen; William Baaré; Gitte M Knudsen; Steen G Hasselbalch
Journal:  Psychopharmacology (Berl)       Date:  2010-07-10       Impact factor: 4.530

6.  Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.

Authors:  Stephen J Kish; Jason Lerch; Yoshiaki Furukawa; Junchao Tong; Tina McCluskey; Diana Wilkins; Sylvain Houle; Jeffrey Meyer; Emanuela Mundo; Alan A Wilson; Pablo M Rusjan; Jean A Saint-Cyr; Mark Guttman; D Louis Collins; Colin Shapiro; Jerry J Warsh; Isabelle Boileau
Journal:  Brain       Date:  2010-05-17       Impact factor: 13.501

7.  Serotonin Transporter Binding Potentials in Brain of Juvenile Monkeys 1 Year After Discontinuation of a 2-Year Treatment With Fluoxetine.

Authors:  Mari S Golub; Casey E Hogrefe; Lillian J Campos; Andrew S Fox
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-07-06

Review 8.  Role of the 5-HTTLPR and SNP Promoter Polymorphisms on Serotonin Transporter Gene Expression: a Closer Look at Genetic Architecture and In Vitro Functional Studies of Common and Uncommon Allelic Variants.

Authors:  Sandra Iurescia; Davide Seripa; Monica Rinaldi
Journal:  Mol Neurobiol       Date:  2015-10-13       Impact factor: 5.590

9.  Risk-seeking for losses is associated with 5-HTTLPR, but not with transient changes in 5-HT levels.

Authors:  Philipp T Neukam; Nils B Kroemer; Yacila I Deza Araujo; Lydia Hellrung; Shakoor Pooseh; Marcella Rietschel; Stephanie H Witt; Uwe Schwarzenbolz; Thomas Henle; Michael N Smolka
Journal:  Psychopharmacology (Berl)       Date:  2018-05-05       Impact factor: 4.530

10.  Cerebral 5-HT2A receptor and serotonin transporter binding in humans are not affected by the val66met BDNF polymorphism status or blood BDNF levels.

Authors:  Anders Bue Klein; Viktorija Trajkovska; David Erritzoe; Steven Haugbol; Jacob Madsen; William Baaré; Susana Aznar; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.